BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24354854)

  • 21. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.
    Heidemann J; Ogawa H; Dwinell MB; Rafiee P; Maaser C; Gockel HR; Otterson MF; Ota DM; Lugering N; Domschke W; Binion DG
    J Biol Chem; 2003 Mar; 278(10):8508-15. PubMed ID: 12496258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
    De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
    J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells.
    Sai J; Walker G; Wikswo J; Richmond A
    J Biol Chem; 2006 Nov; 281(47):35931-41. PubMed ID: 16990258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
    Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
    J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
    Zaslaver A; Feniger-Barish R; Ben-Baruch A
    J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized bacterial infection induces systemic activation of neutrophils through Cxcr2 signaling in zebrafish.
    Deng Q; Sarris M; Bennin DA; Green JM; Herbomel P; Huttenlocher A
    J Leukoc Biol; 2013 May; 93(5):761-9. PubMed ID: 23475575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
    Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
    Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
    Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
    Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis.
    Neel NF; Barzik M; Raman D; Sobolik-Delmaire T; Sai J; Ham AJ; Mernaugh RL; Gertler FB; Richmond A
    J Cell Sci; 2009 Jun; 122(Pt 11):1882-94. PubMed ID: 19435808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.
    Chapman RW; Minnicozzi M; Celly CS; Phillips JE; Kung TT; Hipkin RW; Fan X; Rindgen D; Deno G; Bond R; Gonsiorek W; Billah MM; Fine JS; Hey JA
    J Pharmacol Exp Ther; 2007 Aug; 322(2):486-93. PubMed ID: 17496165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils.
    Teijeira A; Garasa S; Ochoa MDC; Cirella A; Olivera I; Glez-Vaz J; Andueza MP; Migueliz I; Alvarez M; Rodríguez-Ruiz ME; Rouzaut A; Berraondo P; Sanmamed MF; Perez Gracia JL; Melero I
    Eur J Immunol; 2021 Sep; 51(9):2274-2280. PubMed ID: 33963542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human T cells that regulate neutrophilic skin inflammation.
    Schaerli P; Britschgi M; Keller M; Steiner UC; Steinmann LS; Moser B; Pichler WJ
    J Immunol; 2004 Aug; 173(3):2151-8. PubMed ID: 15265952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
    Navarro J
    Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
    Li F; Zhang X; Gordon JR
    Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrimidine-based compounds modulate CXCR2-mediated signaling and receptor turnover.
    Ha H; Neamati N
    Mol Pharm; 2014 Jul; 11(7):2431-41. PubMed ID: 24896229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G Protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions.
    Singh V; Raghuwanshi SK; Smith N; Rivers EJ; Richardson RM
    J Immunol; 2014 Mar; 192(5):2186-94. PubMed ID: 24510965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.